A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer https://t.co/EQiGyCpf2Z https://t.co/z6Ow427Roa
3,306 followers
3,306 followers
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer https://t.co/EQiGyCpf2Z https://t.co/r61qJw0dfT
3,306 followers
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer https://t.co/EQiGyCpf2Z https://t.co/s4pHeXtd52
3,306 followers
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer https://t.co/EQiGyCpf2Z https://t.co/ez0uFjAHw9